Biodesix (BDSX) Enterprise Value (2019 - 2025)
Biodesix (BDSX) has disclosed Enterprise Value for 7 consecutive years, with -$19.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 27.65% year-over-year to -$19.0 million, compared with a TTM value of -$19.0 million through Dec 2025, up 27.65%, and an annual FY2025 reading of -$19.0 million, up 27.65% over the prior year.
- Enterprise Value was -$19.0 million for Q4 2025 at Biodesix, down from -$16.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$11.5 million in Q1 2024 and bottomed at -$56.3 million in Q2 2021.
- Average Enterprise Value over 5 years is -$28.2 million, with a median of -$24.5 million recorded in 2022.
- The sharpest move saw Enterprise Value crashed 660.52% in 2021, then soared 70.31% in 2022.
- Year by year, Enterprise Value stood at -$32.8 million in 2021, then plummeted by 31.32% to -$43.1 million in 2022, then surged by 39.0% to -$26.3 million in 2023, then increased by 0.15% to -$26.2 million in 2024, then increased by 27.65% to -$19.0 million in 2025.
- Business Quant data shows Enterprise Value for BDSX at -$19.0 million in Q4 2025, -$16.6 million in Q3 2025, and -$20.7 million in Q2 2025.